Taylor Wessing advises PanOpSys Limited on $5.25 million Series A funding with Quester
08-Mar-2006 | Corporate, Employment & Pensions
CLIENT
PanOpSys
VALUE
$5.25 million
TRANSACTION
Series A funding round
DESCRIPTION
The venture capital group at European law firm, Taylor Wessing, has advised PanOpSys Limited, a medical diagnostics company focusing on rapid quantitative detection of disease markers, on the raising of $5.25 million following a Series A funding from Quester.
